This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Oct;45(4):473-5.

doi: 10.1016/j.jhep.2006.07.007. Epub 2006 Jul 25.

Endpoints for clinical trials on treatment of hepatitis C

Hellan Kang, Anna S F Lok

PMID: 16901577
DOI: 10.1016/j.jhep.2006.07.007

Review

Endpoints for clinical trials on treatment of hepatitis C

Hellan Kang et al. J Hepatol. 2006 Oct.

. 2006 Oct;45(4):473-5.

doi: 10.1016/j.jhep.2006.07.007. Epub 2006 Jul 25.

Authors

Hellan Kang, Anna S F Lok

PMID: 16901577
DOI: 10.1016/j.jhep.2006.07.007

No abstract available

PubMed Disclaimer

Comment on

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, Kullak-Ublick GA, Gerken G, Zeuzem S, Nevens F, Tielemans WC, Zondervan PE, Lagging M, Westin J, Schalm SW. Orlent H, et al. J Hepatol. 2006 Oct;45(4):539-46. doi: 10.1016/j.jhep.2006.05.015. Epub 2006 Jun 30. J Hepatol. 2006. PMID: 16905220 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information